Moran Sean F.

USNatural personCFO

Transactions

106

Issuers

Buys / Sells

53/12

Last tx

13 Feb 2026

FrançaisSign in Try free 14d

Insider

Moran Sean F.

USNatural personCFO

Transactions

106

Issuers

Buys / Sells

53/12

Last tx

13 Feb 2026

Behaviour

2 purchases reported after at least 12 months of silence — most recent on 10 Mar 2022.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Corbus Pharmaceuticals Holdings, Inc.	96,694	reported	13 Feb 2026	tx 96+4,218,830−427,394
Design Source, Inc.	60,000	reported	03 Sept 2013	tx 5+100,000
Imunon, Inc.	35,000	reported	17 Mar 2009	tx 7+155,000

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Feb 2026	SALE	Corbus Pharmaceuticals Holdings, Inc.	4,701	7.78 USD
14 Jan 2026	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	28,082	0.00 USD
14 Jan 2026	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	84,247	0.00 USD	deriv
24 Oct 2025	SALE	Corbus Pharmaceuticals Holdings, Inc.	12,981	17.02 USD
24 Oct 2025	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	12,981	4.26 USD
24 Oct 2025	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	12,981	0.00 USD	deriv
14 Feb 2025	SALE	Corbus Pharmaceuticals Holdings, Inc.	2,792	8.76 USD
31 Jan 2025	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	27,500	0.00 USD
31 Jan 2025	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	92,500	0.00 USD	deriv
17 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	6,730	46.77 USD
18 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,958	30.00 USD
18 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	1,958	42.12 USD
17 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	6,730	14.10 USD
14 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	7,788	49.87 USD
14 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	1,567	49.87 USD
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,567	30.00 USD
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	7,788	4.26 USD
18 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,958	0.00 USD	deriv
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	7,788	0.00 USD	deriv
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,567	0.00 USD	deriv
17 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	6,730	0.00 USD	deriv
10 Apr 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,787	30.00 USD
10 Apr 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,787	0.00 USD	deriv
12 Feb 2024	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	40,176	0.00 USD
12 Feb 2024	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	40,176	0.00 USD	deriv

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Corbus Pharmaceuticals Holdings, Inc.	96,694	reported	13 Feb 2026	tx 96+4,218,830−427,394
Design Source, Inc.	60,000	reported	03 Sept 2013	tx 5+100,000
Imunon, Inc.	35,000	reported	17 Mar 2009	tx 7+155,000

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Feb 2026	SALE	Corbus Pharmaceuticals Holdings, Inc.	4,701	7.78 USD
14 Jan 2026	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	28,082	0.00 USD
14 Jan 2026	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	84,247	0.00 USD	deriv
24 Oct 2025	SALE	Corbus Pharmaceuticals Holdings, Inc.	12,981	17.02 USD
24 Oct 2025	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	12,981	4.26 USD
24 Oct 2025	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	12,981	0.00 USD	deriv
14 Feb 2025	SALE	Corbus Pharmaceuticals Holdings, Inc.	2,792	8.76 USD
31 Jan 2025	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	27,500	0.00 USD
31 Jan 2025	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	92,500	0.00 USD	deriv
17 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	6,730	46.77 USD
18 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,958	30.00 USD
18 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	1,958	42.12 USD
17 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	6,730	14.10 USD
14 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	7,788	49.87 USD
14 Jun 2024	SALE	Corbus Pharmaceuticals Holdings, Inc.	1,567	49.87 USD
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,567	30.00 USD
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	7,788	4.26 USD
18 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,958	0.00 USD	deriv
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	7,788	0.00 USD	deriv
14 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,567	0.00 USD	deriv
17 Jun 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	6,730	0.00 USD	deriv
10 Apr 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,787	30.00 USD
10 Apr 2024	EXERCISE	Corbus Pharmaceuticals Holdings, Inc.	1,787	0.00 USD	deriv
12 Feb 2024	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	40,176	0.00 USD
12 Feb 2024	GRANT_AWARD	Corbus Pharmaceuticals Holdings, Inc.	40,176	0.00 USD	deriv